Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone in chronic critically ill patients (RAS-ICU)
NCT03038919Phase 3Unknown
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone cypionate in Critical Illness Polyneuropathy (CIP), sponsored by Hospital de Clínicas de Porto Alegre. Status: unknown.
02
Drugs
testosterone cypionate
03
Conditions
Critical Illness Polyneuropathy (CIP)
Beyond the preview
Go deeper on NCT03038919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03038919.